We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Immune Memory Is Achieved by Epigenetic and Topological Rearrangements of DNA in Immune Cells

Representation of human cells.
Credit: Skylarvision / Pixabay
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 2 minutes

The immune system is one of the most complex parts of our body. It keeps us healthy by getting rid of parasites, viruses or bacteria, and by destroying damaged or cancer cells. One of its most intriguing abilities is its memory: upon first contact with a foreign component (called “antigens” in scientific jargon) our adaptive immune system takes around two weeks to respond, but responses afterwards are much faster, as if the cells “remembered” the antigen. But how is this memory attained? In a recent publication, a team of researchers coordinated by Dr. Ralph Stadhouders, from Erasmus MC, and Dr. Gregoire Stik, Group Leader at the Josep Carreras Leukaemia Research Institute, provides new clues on immune memory using state-of-the-art methodologies.


In their research paper, published in the prestigious scientific journal Science Immunology, the first-author Anne Onrust-van Schoonhoven and colleagues compared the response of immune cells that had never been in contact with an antigen (called naïve cells) with cells previously exposed to antigen (memory cells) and sort of knew it. They focused on the differences in the epigenetic control of the cellular machinery and the nuclear architecture of the cells, two mechanisms that could explain the quick activation pattern of memory cells.


Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

While all the cells in an individual have the same genetic information, different cell types have access to different parts of the DNA. The term "epigenetics" encompasses the mechanisms that dynamically control this access. The results of the research team revealed a particular epigenetic signature in memory cells, resulting in the rapid activation of a crucial set of genes compared to naive cells. These genes were much more accessible to the cellular machinery, in particular to a family of transcription factors called AP-1. To put it into a racing context: these genes have been warming-up ever since the cell’s first contact with the antigen.


However, this epigenetic signature was just the tip of the iceberg. It is known that the position of the DNA in the nucleus is not random and reflects the cell’s activation state. The researchers found that, indeed, the 3D distribution of DNA in the nucleus is different between naïve and memory immune cells. Key genes for the early immune response are grouped together and under the influence of the same regulatory regions, called enhancers. Keeping with the racing metaphor, the genes are not only warmed-up, but also gathered together at the starting line.


Although most of the research has focused on healthy cells, the scientific team wondered whether any of the mechanisms found could, when altered, explain actual diseases in which the immune system plays an important role. To address this question, they analyzed immune cells from chronic asthma patients and found that the circuits identified as key for an early and strong immune response were overactivated.


The epigenetic control of the immune system is a blossoming field and discoveries like the ones by Dr. Stik and colleagues are setting the stage for the next generation of epigenetic drugs and treatments, targeting autoimmune diseases and cancer.

Reference: Onrust-van Schoonhoven A, De Bruijn MJW, Stikker B, et al. 3D chromatin reprogramming primes human memory TH2 cells for rapid recall and pathogenic dysfunction. Sci Immunol. 2023;8(85):eadg3917. doi: 10.1126/sciimmunol.adg3917


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.